Our first experience with subtreshold diode laser in the treatment of macular edema
Authors describe their first experience with the treatment of macular edema of different etiology with subtreshold diode micropulse laser (577 nm), which does not cause any damage to the retinal pigment epithelium.
Davorin Sevšek +2 more
doaj
Purpose. To study the safety and effectiveness of subthreshold micropulse (SML) 577 nm laser therapy with an individual power titration in treating patients with chronic central serous chorioretinopathy (CSC). Methods. The study was a prospective, single-
Taras Kustryn +4 more
doaj +1 more source
Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
Ahmed Hosni Abd ElhamidDepartment of Ophthalmology, Ain Shams University, Cairo, EgyptPurpose: To report the efficacy and safety of micropulse 577 nm yellow laser in the treatment of nonresolving central serous chorioretinopathy (CSC) cases.Patients
Abd Elhamid AH
doaj
Micropulse Transscleral Cyclophotocoagulation
Soshian Sarrafpour +3 more
openaire +1 more source
Phakomatosis Pigmentovascularis (Type IIb) With Bilateral Glaucoma and Urrets-Zavalia Syndrome Following MicroPulse TSCPC: A Case Report. [PDF]
Alshehri A, Thabet YB, Almutairi MN.
europepmc +1 more source
Comparative Efficacy and Safety of Micropulse Versus Continuous-Wave Transscleral Cyclophotocoagulation in the Management of Refractory Glaucoma: A Prospective Cohort Study. [PDF]
Yang S, Liu X, Xie J, Zhao C.
europepmc +1 more source
Commentary on: Micropulse transscleral cyclophotocoagulation: Redefining the role of cyclodestruction in glaucoma management. [PDF]
Kavitha S, Tejaswini US.
europepmc +1 more source
Comparison of the efficacy of subthreshold micropulse laser versus intravitreal anti-VEGF therapy for chronic central serous chorioretinopathy. [PDF]
Li J +5 more
europepmc +1 more source

